Pos | No | Age | Sex | Organ_Anatomic_Site | Pathology_diagnosis | Grade | TNM | Stage | Type |
A1 | 1 | 65 | M | Prostate | Ductal adenocarcinoma 3(3+5) | * | T2N0M0 | IIB | Malignant |
A2 | 2 | 57 | M | Prostate | Ductal adenocarcinoma 3(3+4) | * | T2aN0M0 | IIA | Malignant |
A3 | 3 | 70 | M | Prostate | Ductal adenocarcinoma 3(3+4) | * | T2N0M0 | IIA | Malignant |
A4 | 4 | 73 | M | Prostate | Cribriform ductal adenocarcinoma 4(3+4) | * | T2aN0M0 | IIA | Malignant |
A5 | 5 | 65 | M | Prostate | Cribriform ductal adenocarcinoma 3(3+3) | * | T2N0M0 | IIA | Malignant |
A6 | 6 | 60 | M | Prostate | Ductal adenocarcinoma 4(4+4) | * | T3N1M0 | IV | Malignant |
A7 | 7 | 64 | M | Prostate | Ductal adenocarcinoma 4(4+3) | * | T2N0M0 | IIA | Malignant |
A8 | 8 | 73 | M | Prostate | Cribriform ductal adenocarcinoma 4(4+3) | * | T3N0M0 | III | Malignant |
A9 | 9 | * | * | Blank | Blank | * | * | * | * |
B1 | 10 | 70 | M | Prostate | Cribriform ductal adenocarcinoma 4(4+3) | * | T3N0M0 | III | Malignant |
B2 | 11 | 56 | M | Prostate | Ductal adenocarcinoma 4(4+3) | * | T3N0M0 | III | Malignant |
B3 | 12 | 73 | M | Prostate | Ductal adenocarcinoma 3(3+4) | * | T3N0M0 | III | Malignant |
B4 | 13 | 82 | M | Prostate | Cribriform ductal adenocarcinoma 4(4+5) | * | T2N0M0 | IIB | Malignant |
B5 | 14 | 66 | M | Prostate | Ductal adenocarcinoma 4(3+5) | * | T3aN0M0 | III | Malignant |
B6 | 15 | 81 | M | Prostate | Ductal adenocarcinoma 4(3+5) | * | T3aN0M0 | III | Malignant |
B7 | 16 | 64 | M | Prostate | Ductal adenocarcinoma 4(4+3) | * | T2N0M0 | IIA | Malignant |
B8 | 17 | 75 | M | Prostate | Cribriform ductal adenocarcinoma 4(3+5) | * | T2N0M0 | IIB | Malignant |
B9 | 18 | * | * | Blank | Blank | * | * | * | * |
C1 | 19 | 76 | M | Prostate | Cribriform ductal adenocarcinoma 4(4+4) | * | T3N0M0 | III | Malignant |
C2 | 20 | 62 | M | Prostate | Ductal adenocarcinoma 4(4+4) | * | T3N0M0 | III | Malignant |
C3 | 21 | 68 | M | Prostate | Cribriform ductal adenocarcinoma 4(4+4) | * | T2bN0M0 | IIB | Malignant |
C4 | 22 | 73 | M | Prostate | Cribriform ductal adenocarcinoma 4(4+4) | * | T3N1M0 | IV | Malignant |
C5 | 23 | 63 | M | Prostate | Cribriform ductal adenocarcinoma 5(5+5) | * | T2N0M0 | IIB | Malignant |
C6 | 24 | 62 | M | Prostate | Cribriform ductal adenocarcinoma 4(4+4) | * | T2N0M0 | IIB | Malignant |
C7 | 25 | 62 | M | Prostate | Ductal adenocarcinoma 4(3+4) | * | T3N0M0 | III | Malignant |
C8 | 26 | 73 | M | Prostate | Ductal adenocarcinoma 3(3+3) | * | T2aN0M0 | IIA | Malignant |
C9 | 27 | * | * | Blank | Blank | * | * | * | * |
D1 | 28 | 70 | M | Prostate | Cribriform ductal adenocarcinoma 4(4+4) | * | T3N0M0 | III | Malignant |
D2 | 29 | 80 | M | Prostate | Cribriform ductal adenocarcinoma 4(4+4) | * | T3N0M0 | III | Malignant |
D3 | 30 | 78 | M | Prostate | Ductal adenocarcinoma with neuroendocrine differentiation 4(4+5) | * | T4N0M0 | IV | Malignant |
D4 | 31 | 60 | M | Prostate | Ductal adenocarcinoma 4(5+3) | * | T3N0M0 | III | Malignant |
D5 | 32 | 69 | M | Prostate | Ductal adenocarcinoma 3(3+3) | * | T3N0M0 | III | Malignant |
D6 | 33 | 65 | M | Prostate | Ductal adenocarcinoma 5(5+4) | * | T2N0M0 | IIB | Malignant |
D7 | 34 | 76 | M | Prostate | Ductal adenocarcinoma 5(5+4) | * | T3N0M0 | III | Malignant |
D8 | 35 | 60 | M | Prostate | Solid ductal adenocarcinoma 5(5+5) | * | T2N0M0 | IIB | Malignant |
D9 | 36 | * | * | Blank | Blank | * | * | * | * |
E1 | 37 | 71 | M | Prostate | Atrophic acinar adenocarcinoma 3(3+3) | * | T2aN0M0 | IIA | Malignant |
E2 | 38 | 64 | M | Prostate | Acinar adenocarcinoma 5(5+5) | * | T2aN0M0 | IIB | Malignant |
E3 | 39 | 66 | M | Prostate | Acinar adenocarcinoma 3(3+3) | * | T2N0M0 | IIA | Malignant |
E4 | 40 | 68 | M | Prostate | Acinar adenocarcinoma 3(3+4) | * | T2N0M0 | IIA | Malignant |
E5 | 41 | 69 | M | Prostate | Acinar adenocarcinoma 3(3+3) | * | T2N0M0 | IIA | Malignant |
E6 | 42 | 20 | M | Prostate | Acinar adenocarcinoma 4(4+4) | * | T3N0M0 | III | Malignant |
E7 | 43 | 74 | M | Prostate | Acinar adenocarcinoma 3(3+3) | * | T2N0M0 | IIA | Malignant |
E8 | 44 | 70 | M | Prostate | Acinar adenocarcinoma 4(4+4) | * | T2aN0M0 | IIB | Malignant |
E9 | 45 | 72 | M | Prostate | Acinar adenocarcinoma 5(5+5) | * | T3N0M0 | III | Malignant |
F1 | 46 | 38 | M | Prostate | Prostate tissue | * | * | * | Normal |
F2 | 47 | 36 | M | Prostate | Prostate tissue | * | * | * | Normal |
F3 | 48 | 30 | M | Prostate | Prostate tissue | * | * | * | Normal |
F4 | 49 | 31 | M | Prostate | Prostate tissue | * | * | * | Normal |
F5 | 50 | 31 | M | Prostate | Prostate tissue | * | * | * | Normal |
F6 | 51 | 29 | M | Prostate | Prostate tissue | * | * | * | Normal |
F7 | 52 | 34 | M | Prostate | Prostate tissue | * | * | * | Normal |
F8 | 53 | 35 | M | Prostate | Prostate tissue | * | * | * | Normal |
F9 | 54 | 35 | M | Prostate | Prostate tissue | * | * | * | Normal |